Product Details

Olanzapine + Fluoxetine Tablets BP 25 mg (VEROLAN-F) combine olanzapine, an atypical antipsychotic, with fluoxetine, an SSRI antidepressant. The product packaging states that the tablets meet British Pharmacopoeia (BP) standards.

Healthcare professionals may prescribe the olanzapine and fluoxetine combination for appropriate patients with depressive episodes associated with Bipolar I Disorder and treatment-resistant depression, in accordance with applicable prescribing information.

What Are Olanzapine and Fluoxetine Tablets?

AYUOLANZ-F contains two active pharmaceutical ingredients with complementary pharmacological properties:

• Olanzapine is an atypical antipsychotic that acts on several neurotransmitter receptor systems in the brain. Healthcare professionals use olanzapine to manage certain psychiatric and mood disorders.
• Fluoxetine is a selective serotonin reuptake inhibitor (SSRI). It increases serotonin activity in the central nervous system and supports the treatment of depressive disorders.

Uses of Olanzapine + Fluoxetine

Doctors may consider the olanzapine and fluoxetine combination for appropriate patients with:

• Depressive episodes associated with Bipolar I Disorder
• Treatment-resistant depression

Patients should take this prescription medicine only under the guidance and supervision of a qualified healthcare professional.

Key Features of VEROLAN-F

• Contains Olanzapine + Fluoxetine
• 25 mg strength, as indicated on the supplied product packaging
• Tablet dosage form for oral administration
• Product packaging states compliance with British Pharmacopoeia (BP) standards
• Combines an atypical antipsychotic with an SSRI antidepressant
• Supports pharmaceutical distribution through hospitals, clinics, pharmacies, and healthcare institutions
• Supplied in 10 × 10 tablet packaging